CRISPR Therapeutics AG (CRSP)

97.00 -1.70  -1.72% NASDAQ Oct 15, 16:00 97.52 +0.52  +0.54% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All CRSP News


View All Events


Date Type Description
10/28/2021 Earnings Results Q3 2021 Earnings Results
07/29/2021 Earnings Results Q2 2021 Earnings Results
06/10/2021 02:00 EST AGM 2021 Annual General Meeting
04/27/2021 Earnings Results Q1 2021 Earnings Results
02/16/2021 Earnings Results Q4 2020 Earnings Results
10/28/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Oct. 28, 2021
  • Last Earnings Release: Jul. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
NEXTX Shelton Green Alpha 4.01%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 3.33%
ARKG ARK Genomic Revolution ETF 3.01%
DSGFX Delaware Small Cap Growth R 2.97%
ARKK ARK Innovation ETF 2.86%
ADNRX American Beacon ARK Transfmt Innov R6 2.62%
F000010GK1 JNL/Loomis Sayles Global Growth A 2.33%
HQL Tekla Life Sciences Investors 1.68%
RYCFX Rydex Biotechnology C 1.52%
BBH VanEck Biotech ETF 1.52%
HQH Tekla Healthcare Investors 1.48%
PJHRX PGIM Jennison Health Sciences R 1.40%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.